NCT01363180 (ARC5) is a clinical trial of Trier Social Stress Test (TSST) in Trauma, sponsored by Medical University of South Carolina.

Who is sponsoring NCT01363180?

NCT01363180 is sponsored by Medical University of South Carolina.

What drugs are being tested in NCT01363180?

Interventions in NCT01363180: Trier Social Stress Test (TSST), No stress condition.

What condition does NCT01363180 study?

NCT01363180 studies Trauma, Posttraumatic Stress Disorder.

Is NCT01363180 still recruiting?

NCT01363180 is currently completed. Last updated 18 June 2018.

Last reviewed 2018-06-18 · How we verify

NCT01363180: ARC5

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stress-induced Drinking in Emerging Adults: the Role of Trauma History

Completed Last updated 18 June 2018

What this trial tests

trial testing Trier Social Stress Test (TSST) in Trauma in 197 participants. Completed in 1 June 2016.

Timeline

1 January 2011

Primary endpoint
31 December 2015

1 June 2016

Quick facts

Lead sponsor	Medical University of South Carolina
Status	Completed
Study type	OBSERVATIONAL
Enrollment	197
Start date	1 January 2011
Primary completion	31 December 2015
Estimated completion	1 June 2016
Sites	1 location across United States

Drugs / interventions tested

Trier Social Stress Test (TSST)
No stress condition

Conditions studied

Trauma — all drugs for Trauma →
Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →

Sponsor

Medical University of South Carolina

Who can join

Adults 21 to 30, any sex, with Trauma or Posttraumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is the first to use a clinical laboratory method in emerging adults to test the hypothesis that a trauma history with or without concommitant posttraumatic stress disorder (PTSD) alters response to a stressor and promotes drinking compared to normal controls. The study will be the first to explore whether trauma-exposed (TE) and PTSD groups differ on these outcomes. It will also examine the relationship between stress reactivity and subsequent stress-induced drinking in these samples. The goal of this program is to better understand the relationship between stress and factors related to the development and maintenance of alcohol problems in early adults, so that ultimately, better treatments may be developed that reduce the incidence and severity of alcohol related problems.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Trier Social Stress Test (TSST)

Trials testing the same drug.

NCT05795179 — Stress & Self-Control Costs · NA · recruiting
NCT05329441 — Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression · recruiting
NCT05310253 — Stress & Social Cognition in BPD (part 2) · NA · completed
NCT04174651 — Stress-induced Scratching in Healthy and AD · NA · completed
NCT02710279 — Response to Social Rejection in Suicidal Behavior · NA · terminated

Other recruiting trials for Trauma

Currently open trials in the same condition.

NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting

Other Medical University of South Carolina trials

Trials by the same sponsor.

NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01363180 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
Last refreshed: 18 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01363180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing